Patents by Inventor Jörn Bullerdiek

Jörn Bullerdiek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS
    Publication number: 20150087694
    Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of tumor involving a chromosomal rearrangement, in particular a tumor or neoplasia of the thyroid gland. In addition, methods of identifying anti-tumor agents are described.
    Type: Application
    Filed: September 8, 2014
    Publication date: March 26, 2015
    Inventors: Joern Bullerdiek, Volkhard Rippe
  • p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth
    Publication number: 20140371237
    Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of leiomyomas, in particular uterine leiomyoma (UL). In addition, methods of identifying anti-tumor agents are described. Furthermore, novel methods and compositions are provided for the treatment of diseases characterized by an aberrant growth of mesenchymal stem cells and their descendants and for the treatment of obesity are disclosed.
    Type: Application
    Filed: August 6, 2014
    Publication date: December 18, 2014
    Inventors: Jörn Bullerdiek, Dominique N. Markowski
  • Microrna-based methods and compositions for the diagnosis, prognosis and treatment of tumor involving chromosomal rearrangements
    Patent number: 8828656
    Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of tumor involving a chromosomal rearrangement, in particular a tumor or neoplasia of the thyroid gland. In addition, methods of identifying anti-tumor agents are described.
    Type: Grant
    Filed: August 31, 2010
    Date of Patent: September 9, 2014
    Assignee: University of Bremen
    Inventors: Joern Bullerdiek, Volkhard Rippe
  • WNT4 AND MED12 FOR USE IN THE DIAGNOSIS AND TREATMENT OF TUMOR DISEASES
    Publication number: 20140248294
    Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of gynecological tumors, in particular uterine leiomyoma (UL). Furthermore, novel methods and compositions for the treatment of diseases characterized by an aberrant growth of mesenchymal stem cells and their descendants and for the treatment of pituitary and prostate tumors are described.
    Type: Application
    Filed: October 5, 2012
    Publication date: September 4, 2014
    Applicant: UNIVERSITY OF BREMEN
    Inventors: Jörn Bullerdiek, Dominique N. Markowski
  • p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth
    Publication number: 20130149314
    Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of leiomyomas, in particular uterine leiomyoma (UL). In addition, methods of identifying anti-tumor agents are described. Furthermore, novel methods and compositions are provided for the treatment of diseases characterized by an aberrant growth of mesenchymal stem cells and their descendants and for the treatment of obesity are disclosed.
    Type: Application
    Filed: February 9, 2011
    Publication date: June 13, 2013
    Inventors: Jörn Bullerdiek, Dominique N. Markowski
  • MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS
    Publication number: 20120295949
    Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of tumor involving a chromosomal rearrangement, in particular a tumor or neoplasia of the thyroid gland. In addition, methods of identifying anti-tumor agents are described.
    Type: Application
    Filed: August 31, 2010
    Publication date: November 22, 2012
    Inventors: Joern Bullerdiek, Volkhard Rippe
  • MEANS AND METHODS FOR THE DETECTION AND ISOLATION OF FETAL AND EMBRYONIC CELLS AND NUCLEIC ACID FROM MATERNAL BODY FLUID
    Publication number: 20100323354
    Abstract: The present invention is related to the use of an interaction partner of a high mobility group protein of the HMGA family for the detection of fetal and embryonic cells in a maternal body fluid.
    Type: Application
    Filed: October 31, 2008
    Publication date: December 23, 2010
    Inventor: Jörn Bullerdiek
  • Multiple-tumor aberrant growth genes
    Patent number: 6544784
    Abstract: The present invention relates to the multi-tumor Aberrant Growth (MAG) gene having the nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions thereof. The gene and its derivatives may be used in various diagnostic and therapeutic applications.
    Type: Grant
    Filed: October 20, 1997
    Date of Patent: April 8, 2003
    Assignee: Vlaams Interuniversitair Instituut Voor Biotechnologie VZW
    Inventors: Jörn Bullerdiek, Willem Jan Marie Van de Ven, Henricus Franciscus Petrus Maria Schoenmakers, Rafaël Mols